Are the Wegovy pill and Ozempic the same thing?

The Wegovy pill and Ozempic share the same active drug, semaglutide. Both medicines are GLP-1 receptor agonists — they mimic the gut hormone GLP-1 your body releases after eating. This helps you to feel full and regulates blood sugar levels. But there are real differences between them.

The UK’s medicines regulator, the MHRA, approved the Wegovy pill in June 2026 for weight management. Dosing starts at 1.5mg taken once daily, on an empty stomach with a minimal amount of water. Treatment climbs to a 25mg maintenance dose over several months.

You qualify for treatment with a body mass index (BMI) of 30 or above. Alternatively, a BMI between 27 and 30 qualifies if you have a weight-related health condition. High blood pressure, raised cholesterol, prediabetes, and sleep apnoea are examples. They all increase the risk of health complications from carrying excess weight.

Ozempic is an injectable semaglutide licensed to treat type 2 diabetes. You inject it once a week, from a 0.25mg starting dose to a 2mg ceiling.

Can I use Ozempic for weight loss instead of the Wegovy pill?

Ozempic has never carried a weight-loss licence in the UK. Some patients have taken it off-label to lose weight anyway. Off-label prescribing means using a medicine outside what its licence covers. 

This use is legal, but Ozempic safety and dosing data come from diabetes studies. It does not come from weight loss trials. 

The other major drawback is that Ozempic only goes up to 2mg a week. This is the dose tested to control blood sugar in people with type 2 diabetes. Ozempic never reaches the maximum dose for weight loss. 

That ceiling matters more than it first looks. Some patients take Ozempic off-label, climb to 2mg and lose weight successfully for a few months. But then they plateau, with no higher rung on the ladder. 

Weighing up Wegovy vs Ozempic for weight loss, the licensed options are the Wegovy pill or the Wegovy injection. We recommend opting for one of these. If your BMI exceeds 30 on start, you can take injectable Wegovy up to a maximum dose of 7.2mg.

Why is the dose so different? 25mg versus 2mg

The numbers are misleading and explained by absorption differences. At first glance, the Wegovy pill at 25mg looks far stronger than Ozempic at 2mg. But you cannot compare milligrams across a tablet and an injection. 

What actually counts is how much semaglutide reaches your blood. Tablets and injections get there by different routes.

A weekly injection delivers semaglutide almost straight into your system. Almost 90% of each injected Ozempic dose reaches your system. But a swallowed tablet has to survive your stomach first. The Wegovy tablet relies on an absorption helper called SNAC to achieve this. 

For SNAC to work, you must follow the fasting rules. Take oral Wegovy after an 8 hour fast (usually overnight) with a small glass of water. Then wait at least 30 minutes before eating, drinking, or taking other medication. 

Even then, only around 1% of each dose reaches your bloodstream. The tablet dose is much higher so that enough gets through to bring results.

The 25mg Wegovy pill was designed to roughly match the 2.4mg weekly Wegovy injection, not lower-dose Ozempic. In the OASIS 4 trial, the tablet produced an average loss of around 13.6% of body weight over 64 weeks. That brings it close to the 2.4mg Wegovy injection. 

Is Rybelsus the same as the Wegovy pill?

Rybelsus and the Wegovy pill share the same drug and the same once-daily tablet form, but they treat different conditions. Rybelsus runs from 3mg up to a maximum of 14mg, a limit set to control blood sugar. It uses the same SNAC technology as oral Wegovy to deliver the active semaglutide to your bloodstream.

Like Ozempic, Rybelsus carries a diabetes licence rather than a weight-loss one. The lower dose ceiling limits its effectiveness for weight management.

When should I see a doctor?

When switching from Ozempic to a licensed weight loss medication, you need a review of your dose, history, and goals. We can help you decide which treatment option will better suit you on this basis — oral Wegovy or a weight-loss injection. Pairing your treatment with a healthy, balanced diet and exercise is what makes it hold over the long term.

Common side effects of semaglutide are the same whether you take Wegovy or Ozempic. They are mostly mild, easing as your body adjusts to the dose. 

Tell our clinical team about nausea, mild vomiting, constipation, or diarrhoea. Ask us too if you are unsure whether to step up, stay on, or pause your dose.

Other symptoms need same-day medical advice, so do not wait. 

SymptomWhat it may meanWhat to do
A lump in your neck, a hoarse voice, or trouble swallowingPossible thyroid problemContact your GP or call NHS 111 the same day
Yellowing of your skin or the whites of your eyes, or steady pain in the upper-right side of your stomachPossible gallbladder problem, such as gallstones
Vomiting or diarrhoea that will not settle, so you cannot keep fluids downDehydration risk
Much less urine than normal, unusually dark urine, or feeling weak and dizzyEarly signs your kidneys are under strain from fluid loss
Severe stomach pain that spreads through to your back, often with vomitingPossible pancreatitis (inflammation of the pancreas)Stop semaglutide. Call 999 or go to A&E
Sudden loss of vision, or sudden blurring, in one eyeRarely, NAION, where blood flow to the optic nerve drops
Confusion, a fast heartbeat, fainting, or passing no urine at allSevere dehydration
Swelling of the face, lips, or throat, or trouble breathingSerious allergic reaction

If you ever have thoughts of harming yourself, please treat it as an emergency. Call 999, go to A&E, or ask for the CRISIS team. You can also call the Samaritans free on 116 123, at any time of day or night. 

Key takeaways

  • Wegovy is approved for weight management; Ozempic is approved for treating type 2 diabetes. Ozempic for weight loss is off-label in the UK.
  • Wegovy pill’s 25mg is not stronger than Ozempic’s 2mg; it simply reflects how little of the tablet your body absorbs.
  • Oral Wegovy 25mg gives a similar average weight loss to the 2.4mg Wegovy injection in trials.
  • Rybelsus is oral semaglutide too, but its 14mg ceiling keeps it licensed for diabetes rather than weight loss.

References

Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4), New England Journal of Medicine, 2025 [Accessed 29 June 2026].

Semaglutide: a medicine to manage type 2 diabetes or treat obesity, NHS, 2026 [Accessed 29 June 2026]. 

Wegovy 25 mg tablets – Summary of Product Characteristics, electronic medicines compendium, 2026 [Accessed 29 June 2026].

Ozempic 2 mg solution for injection in pre-filled pen – Summary of Product Characteristics, electronic medicines compendium, 2026 [Accessed 29 June 2026].

Rybelsus 14 mg – Summary of Product Characteristics, electronic medicines compendium, 2026 [Accessed 29 June 2026].

First GLP-1 tablet for weight loss approved in the UK, GOV.UK (MHRA), 2026 [Accessed 29 June 2026].

Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only, GOV.UK (MHRA), 2026 [Accessed 29 June 2026]. 

Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), GOV.UK (MHRA), 2026 [Accessed 29 June 2026]. 

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases, GOV.UK (MHRA), 2026 [Accessed 29 June 2026].